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Abstract
Objective. Our aim was to evaluate possible associations between consumption of micronutrients involved in one-carbon
metabolism, MTHFR genotypes, and global DNA methylation in pregnant women.
Methods. A semi-quantitative dietary questionnaire was administered to 195 women during their ﬁrst trimester in Morelos,
Mexico. Two functional polymorphisms of the key folate-metabolizing gene, i.e. MTHFR 677 C4T and 1298 A4C, as well as
global DNA methylation were assessed in peripheral blood drawn during the interview.
Results. Independent of maternal age and caloric intake, vitamin B6 deﬁciency was associated with 1.8 fold increased risk of
hypomethylation in women carrying the MTHFR 677 T allele.
Conclusions. There exists a subpopulation that is more susceptible to B vitamin deﬁciencies.
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Introduction
Fetal growth places a high demand on the regulation of DNA
synthesis and transcription. The regulation of gene transcrip-
tion is partially dependent on DNA methylation, which
utilizes methyl groups supplied by micronutrients in the
one-carbon metabolic pathway. Consequently, inadequate
consumption of methyl-related micronutrients, e.g. vitamins
B2 (riboﬂavin), B6 (pyridoxine), B9 (folate), B12 (cobalamin),
betaine, choline, and methionine, may result in aberrant DNA
methylation. The possibility that aberrant DNA methylation is
a mechanism in which micronutrient deﬁciencies lead to
clinical manifestations remains relatively underexplored given
the number of clinical manifestation that can result from
deﬁciencies. Indeed, maternal deﬁciencies in some of these
micronutrients contribute to neural tube defects (B6,B 9,B 12),
cardiac defects (B6,B 9), premature birth (B9), anemia (B6,B 9,
B12), teratogenesis (B12), neurological abnormalities such as
neonatal demyelination (B12), convulsions (B6), brain atrophy
(B12), cardiovascular disease (B6,B 9), and cancer (B6,B 9,
B12) [1–3].
The rate of one-carbon metabolism is limited by methy-
lenetetrahydrofolate reductase (MTHFR). MTHFR irrever-
sibly catalyzes methyl donation of 5,10-methylene-
tetrahydrofolate to form 5-methyl-tetrahydrofolate, which in
turn provides a methyl group to homocysteine to form
methionine [4]. Catalytic activity of MTHFR is reduced to
45% and 68% of the wild type activity when MTHFR is
homozygous for the MTHFR variants 677T and 1298C,
respectively [5]. Numerous evidence indicates that reduced
MTHFR activity associated with these variants is associated
with decreased DNA methylation [6]. For instance, MTHFR
677 TT carriers have reduced DNA methylation in their
placentas [7]. We previously reported that low activity
MTHFR 677 and 1298 variants increase the risk of
spontaneous abortion [8]. Further, MTHFR variants are
frequently reported to interact with micronutrients to inﬂu-
ence the efﬁciency of this pathway. For instance, we have
found that maternal folate deﬁciencies increased the risk of
poor mental development only in offspring of mothers
carrying the MTHFR 677 TT genotype [9]. Further, both
MTHFR 677 C4T and 1298 A4C polymorphisms interact
with methyl-donating micronutrient levels, e.g. B2,B 12 and
methionine, on risk of cancer [10,11].
Despite the numerous health consequences of vitamin B
deﬁciencies, little research links these micronutrient deﬁcien-
cies and poor health outcomes to DNA methylation. One
recent study found that maternal deﬁciency in vitamin B and
decreased DNA methylation (hypomethylation) in nervous
tissue was signiﬁcantly associated with neural tube defects in
stillborns [12]. Unfortunately, this study did not examine
whether MTHFR allele status modiﬁed these effects. To the
best of our knowledge, the inﬂuence of one-carbon metabo-
lism on DNA methylation in pregnant woman has never been
studied. Here we seek to identify whether deﬁciencies in a
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ents and inherited genetic variability in MTHFR work
together to inﬂuence the extent of global DNA methylation
in pregnant women.
Methods
Population
A cohort of 996 women from the State of Morelos, in Mexico,
was enrolled in 2001. These reproductive-age women were
included if they fulﬁlled ﬁve criteria: (1) expressed intention to
live in select counties from 2001 to 2003, (2) were not breast
feeding, (3) did not use anticonvulsive drugs, (4) had no
renal-, hepatic-, digestive- or thyroid-pathology history, and
(5) did not use permanent contraceptive. Further cohort
details are documented elsewhere [13]. Brieﬂy, these women
were enrolled in the cohort prior to conception. As part of
their prenatal follow-up during a structured interview in the
ﬁrst trimester, maternal dietary information was collected and
a blood sample was obtained. For the present study, we have
complete information from 195 women. These women were
slightly younger on average than the women of the original
cohort (21.7 vs. 22.8 years old, respectively, p-value50.01).
This study was approved by the Institutional Review Board of
the National Institute of Public Health in Mexico.
Diet
Maternal dietary habits during the ﬁrst trimester of pregnancy
were evaluated using a validated semi-quantitative food
frequency questionnaire [14,15]. Brieﬂy, the questionnaire
included information about 95 foods divided into 11 groups
(milk products, fruits, meats, vegetables, legumes, cereals,
drinks, oils, local dishes, sodas, and candies) and it considered
10 categories of consumption frequency, from ‘never’ up to
‘six times a day’ [9,14,16]. Consumption of fruits and
vegetables was adjusted according to availability in the market
during the year. For example, in the case of plums, which
were only available for 6 months of the year, the reported
frequency was divided by two.
The dietary intake of B vitamins (B2,B 6,B 9, and B12) was
estimated through the computer program developed by the
University of Texas (Food Intake Analysis System 3.0) as
previously described [14]. Speciﬁcally, liver, beans, lentils,
green beans, peas, tomatoes, spinach, lettuce, potatoes,
cauliﬂower, broccoli, chili peppers, beets, carrots, avocados,
oranges, papayas, mangos, strawberries, bananas, tangerines,
melons, plums, pears, pineapples, apples, peaches, grapes,
lamb, tuna, pork, and steak were considered dietary sources of
vitamins B2,B 6, and B9. Further, the estimated dietary intake
of vitamin B12 was based in the consumption of liver, sardines,
tuna, pork, lamb, steak, ﬁsh, chocolate, beer, as well as red
and white wines. For the purpose of this study, the nutrient
tables were updated with betaine and choline contents
reported by the US Department of Agriculture [17] and with
methionine from the food composition tables of the ‘Salvador
Zubira ´n’ National Institute of Nutrition [18].
Genetic and epigenetic analyses
Maternal blood was collected for genetic and epigenetic
analyses. Global DNA methylation (%) was ascertained by the
LUminometric Methylation Assay method [19]. Brieﬂy,
blood DNA was co-digested with either HpaII and EcoRI or
MspI and EcoRI (New England Biolabs) and DNA fragments
were sequenced (GTGTCACATGTGTG) using a Q24
pyrosequencer (Qiagen) [20]. Lambda DNA and lambda
treated with the CpG methyltransferase M.SssI, were used as
negative and positive controls, respectively (New England
Biolabs). Maternal MTHFR genotypes (C677T and A1298C)
were determined by PCR-RFLP [9,16].
Statistical analyses
The World Health Organization (WHO) recommended
nutrient intake values for pregnant women were used to
deﬁne the reference groups of the following nutrients:4
1.4 mg vitamin B2 (riboﬂavin),4 1.9 mg vitamin B6 (pyr-
idoxine),4 600 mg vitamin B9 (dietary folate equivalents),
and4 2.6 mg vitamin B12 (cobalamin) [21].
The WHO does not make recommendations for the intake
of choline; therefore the reference group for choline was
deﬁned as daily intake that meets or exceeds 425 mg, based
on the adequate intake recommended for women by the
Institute of Medicine (IoM) [22]. Neither the WHO nor IoM
has recommendations for the intake of betaine or methionine,
and the reference groups for these micronutrients were
deﬁned as at or above the median daily value within the
study population.
DNA methylation (%) was not normally distributed
(Shapiro–Wilk p-value50.0001), and while squaring methy-
lation resulted in a normal distribution, neither the DNA
methylation (%) nor the transformed (%
2) had homoscedas-
ticity of variance, which violates linear regression assump-
tions. Therefore, DNA methylation was dichotomized where
DNA methylation levels below the median DNA methylation
level measured in this population were considered adverse
outcomes, hereafter referred to as DNA hypomethylation
[23]. The MTHFR 677 CC and 1298 AA genotypes were
considered wild type because they are associated with
maximal MTHFR catalytic activity [5]. MTHFR dominance
was deﬁned as the combination of the heterozygous- and the
homozygous low catalytic activity-alleles compared to wild-
type, e.g. MTHFR 677 TT and CT carriers compared to
MTHFR 677 CC, and MTHFR 1298 CC and AC carriers
compared to MTHFR 1298 AA carriers. Hardy–Weinberg
equilibrium was assessed for MTHFR 1298 and MTHFR 677.
Relative risks (RR) of DNA hypomethylation associated
with micronutrient deﬁciencies or MTHFR (dominance
model of 677 T and 1298 C alleles) were estimated by
multivariate general linear models [24]. As our a priori
hypothesis was that micronutrient deﬁciencies and low activity
MTHFR genotypes would increase the risk of DNA hypo-
methylation, no corrections were made for multiple compar-
isons [25,26]. Interaction between micronutrients and
genotypes was only to be evaluated if there was a signiﬁcant
main effect of a micronutrient or MTHFR genotype on risk of
DNA hypomethylation.
The following potential covariates were considered: ma-
ternal age (520 years old, 20–24 years old, 24 years old),
education ( 12 years,412 years), parity (nulliparous, multi-
parous), ﬁrst trimester BMI (underweight, normal, over-
weight, obese), tobacco use during pregnancy (none, used),
alcohol use during pregnancy (none,  1 cup/week), gesta-
tional age (estimated by reported date of last menstrual
period), and offspring sex (obtained during the postpartum
interview).
For each micronutrient or MTHFR model, we assessed
potential confounding by three criteria. First we examined the
w
2 test of independence (p-value50.1) between either the
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Next, we evaluated the w
2 test of independence (p-value5
0.1) between DNA hypomethylation and potential confoun-
ders when the micronutrients status was restricted to
adequate, or when genotypes were wild type. Finally, among
potential confounders identiﬁed with w
2 test of independence
(p-value50.1) in the ﬁrst two steps, confounders were
identiﬁed if they changed the b estimate of the micronutrient
by greater than 10%. If a micronutrient signiﬁcantly altered
the RR of hypomethylation, we evaluated whether this
association could be modiﬁed by MTHFR status. Multi-
plicative interaction of a micronutrient and MTHFR (dom-
inance models of 677 T and 1298 C alleles) was assessed by
the Breslow–Day test for homogeneity. Further evaluation of
potential micronutrient effect modiﬁcation by MTHFR status
was assessed by stratifying the MTHFR dominance categories.
Within each MTHFR stratum, the RR of hypomethylation
due to a micronutrient independent of confounders was
assessed [27]. All statistical analyses were performed using
Statistical Analysis Software, Version 9 (Cary, NC).
Results
The mean percent DNA methylation was 58.8% (standard
deviation 11.4) and its median was 59.8 (range 10.8%–
86.7%). The majority of women had less than 12 years of
education, were nulliparous, and had a normal BMI in early
pregnancy (81.0%, 84.6%, and 64.1%, respectively; Table I).
Tobacco and alcohol use during pregnancy were reported by
10% and 16% of the women respectively (Table I).
MTHFR 677 C4T and 1298 A4C were in Hardy–
Weinberg equilibrium (p-value4 0.4). MTHFR 677 CC, CT,
and TT genotypes occurred in 16%, 51%, and 33% of the
pregnant women, respectively. The crude risk of hypomethy-
lation associated with MTHFR 677 CT and TT genotypes
relative to the MTHFR 677 CC genotype was not signiﬁcant
(1.05; 95% CI: 0.71, 1.55 and 0.91; 95% CI: 0.60, 1.39,
respectively). The prevalence of MTHFR 1298 AA and AC
frequencies was 78% and 22%, respectively, with no observed
MTHFR 1298 CC carriers. None of the maternal character-
istics described in Table I were signiﬁcantly associated with
DNA hypomethylation risk.
Among the study population, 2.0 mg vitamin B1, 2.0 mg
vitamin B2, 1.9 mg vitamin B6, 350.3 mg vitamin B9, 3.6 mg
vitamin B12, 37.6 mg betaine, 333.4 mg choline, and
1,813.0 mg methionine were consumed on average daily.
According to WHO and IoM guidelines, vitamin B6, choline,
and vitamin B9 were the micronutrients in deﬁciency among
the majority of pregnant women observed (61.0%, 78.0%,
and 91.3%, respectively; Table II). Independent of maternal
age and total caloric consumption, the inadequate intake of
vitamin B6 was associated with a signiﬁcant increase of nearly
doubled risk of DNA hypomethylation (1.80; 95% CI: 1.24,
2.61; Table II). Deﬁciencies in the consumption of other
micronutrients involved in one-carbon metabolism were not
associated with risk of DNA hypomethylation in pregnant
women (Table II).
Vitamin B6 deﬁciency and MTHFR 677 (domi-
nance model) signiﬁcantly interacted on the risk of DNA
Table I. Selected maternal characteristics of the population for which
DNA methylation in maternal blood was evaluated (n = 195).
DNA hypomethylation
Maternal
characteristics n % n Prevalence
Crude RR
(95% CI)
Age
520 years old 64 32.8 35 54.7 1.00
20–24 years old 74 38.0 31 41.9 0.77 (0.54, 1.08)
 24 years old 57 29.2 34 59.6 1.09 (0.80, 1.48)
Education
 12 years 158 81.0 81 51.3 1.00
412 years 37 19.0 19 51.4 1.00 (0.71, 1.42)
Parity
No previous
pregnancy
165 84.6 87 52.7 1.00
 1 previous
pregnancy
30 15.4 13 43.3 0.82 (0.53, 1.27)
BMI
Underweight 15 7.7 8 53.3 1.04 (0.63, 1.72)
Normal weight 125 64.1 64 51.2 1.00
Overweight 42 21.5 23 54.8 1.06 (0.77, 1.48)
Obese 13 6.7 5 38.5 0.75 (0.37, 1.52)
Tobacco use during pregnancy
None 175 89.7 91 52.0 1.00
Used 20 10.3 9 45.0 0.86 (0.52, 1.43)
Alcohol use during pregnancy
None 164 84.1 86 52.4 1.00
 1 cup/week 31 15.9 14 45.2 0.86 (0.57, 1.30)
MTHFR 1298
AA 158 81.0 78 49.4 1.00
AC þ CC 37 19.0 22 59.5 1.20 (0.88, 1.64)
MTHFR 677
CC 31 15.9 16 51.6 1.00
CT þ TT 164 84.1 84 51.2 0.99 (0.68, 1.44)
Table II. Relative risks of DNA hypomethylation in maternal blood
due to low levels of micronutrients in a Mexican pregnancy cohort
(n¼195).
Methylation Risk Ratio (95% CI)
Micronutrients Hyper Hypo
(mg/day) nnUnadjusted Adjusted*
B1 (Thiamine)
 1.4 81 80 1.00 1.00
51.4 14 20 1.18 (0.86, 1.63) 1.12 (0.75, 1.67)
B2 (Riboﬂavin)
 1.4 81 83 1.00 1.00
51.4 14 17 1.08 (0.76, 1.54) 0.97 (0.63, 1.49)
B6 (Pyridoxine)
 1.9 46 30 1.00 1.00
51.9 49 70 1.45 (1.06, 1.99) 1.80 (1.24, 2.61)
B9 (Folate)
 0.6 9 8 1.00 1.00
50.6 86 92 1.10 (0.65, 1.85) 0.98 (0.56, 1.73)
B12 (Cobalamin)
 0.0026 62 68 1.00 1.00
50.0026 33 32 0.94 (0.70, 1.27) 0.89 (0.65, 1.21)
Betaine
 31.108 52 46 1.00 1.00
531.108 43 54 1.19 (0.90, 1.56) 1.15 (0.843, 1.56)
Choline
 425 23 20 1.00 1.00
5425 72 80 1.13 (0.79, 1.61) 1.01 (0.66, 1.53)
Methionine
 1755.311 51 46 1.00 1.00
51755.311 44 54 1.16 (0.88, 1.53) 1.08 (0.74, 1.59)
*Adjusted by maternal age and total caloric consumption.
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homogeneity p-value¼0.02; Table III). Among MTHFR
677 TT and CT carriers, vitamin B6 deﬁciency increased
the risk of DNA hypomethylation 1.79 times over the risk of
hypomethylation associated with vitamin B6 adequacy (95%
CI: 1.13, 2.85; Table III). However, vitamin B6 deﬁciency
appeared to have little effect on DNA hypomethylation status
compared to vitamin B6 adequacy in carriers of the CC
genotype (wild-type) of MTHFR 677 (RR¼1.51, 95% CI:
0.57, 4.03; Table III). There was no signiﬁcant interaction
between MTHFR 1298 (dominance model) and vitamin B6
deﬁciency on risk of DNA hypomethylation (Breslow–Day p-
value¼0.79; Table III).
Discussion
The prevalence of vitamin B6-, folate-, and choline-deﬁcien-
cies was high among pregnant Mexican women of this study.
One-carbon metabolism micronutrient deﬁciencies during
pregnancy can have a negative impact on fetal development,
such as increasing risk of neural tube defects and preeclampsia
[1,2,28]. Perhaps these micronutrient deﬁciencies decrease
the production and maintenance of proper DNA methylation
patterns that critically support maternal health and fetal
growth. Vitamin B6 deﬁciency was associated with a modest
increase in risk of DNA hypomethylation in this study and
elsewhere [29]. Although clinically deﬁned vitamin B6
deﬁciency does not always lead to adverse clinical outcomes,
our data suggest that vitamin B6 deﬁciency has a subclinical
presentation, DNA hypomethylation.
Some pregnant women may have greater susceptibility to
the consequences of micronutrient deﬁciencies due to their
inherited genetic variabilities. In particular, our results
indicate that the decreased MTHFR catalytic activity asso-
ciated with MTHFR 677 T alleles may increase susceptibility
to the effect of vitamin B6 deﬁciency on DNA hypomethyla-
tion in pregnant women. Decreased catalytic activity of
MTHFR 1298 AC and CC may also increase the risk of
DNA hypomethylation due to vitamin B6 deﬁciency; however,
the combination of the low prevalence of wild type MTHFR
1298 carriers in this population along with the relatively weak
biological effects of MTHFR 1298 AC and CC likely
underpowered our ability to evaluate this [5].
Increased DNA hypomethylation in pregnant women who
are vitamin B6 deﬁcient and carriers of low activity MTHFR
alleles is biologically plausible given that vitamin B6 is a
necessary cofactor of serine hydroxymethyltransferase, which
produces 5,10-methylenetetrahydrofolate, the MTHFR sub-
strate that provides methyl groups for DNA methylation
[30,31]. Other research suggests that the MTHFR 677 T allele
and vitamin B6 deﬁciency interact to cause adverse health
outcomes. Among carriers of the MTHFR 677 TT genotype,
those with vitamin B6 deﬁciency had greater risk of cancers of
the lungs and colon [10,32] as well as higher levels of plasma
homocysteine [33,34], the later of which is associated with
poor pregnancy outcomes [2,28]. The apparent genetic
susceptibility to the consequences of vitamin B6 deﬁciency
seen on risk of DNA hypomethylation here may further
explain why not all vitamin B6 deﬁcient individuals present
with adverse health.
In what we believe to be the ﬁrst study to examine the
relationships between micronutrient intake, MTHFR status,
and global DNA methylation in pregnant women, our results
are consistent with the hypothesis that deﬁciencies in dietary
vitamin B6 increase DNA hypomethylation more so in carriers
of low activity genetic variants of MTHFR than in carriers of
wild type MTHFR variants. The modest magnitude of DNA
hypomethylation risk reported needs to be conﬁrmed in larger
prospective epidemiology studies to determine whether DNA
methylation mediates the relationship between vitamin B6
deﬁciency, MTHFR, and adverse maternofetal health. More-
over, determination of the effect of vitamin B6 deﬁciency on
the DNA methylation status of cells from MTHFR variant
carriers would be particularly insightful.
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